The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Consistent with the data in mice, the activation of circulating neutrophils as an indicator for the activation status of hepatic neutrophils showed no neutrophil activation during the injury phase but substantial activation (ROS, phagocytosis) selectively during the recovery phase [98]
Transgenic mouse models of alzheimers disease
New research from Simple Online Healthcare suggests oral treatments will significantly expand access to obesity care: 61% of people not currently using GLP-1 medications say they would prefer a daily pill Nearly half of existing GLP-1 users prefer a pill format However, existing patients remain focused on effectiveness 88% saying they would only switch if tablets deliver equal or higher results
Macrophage receptors and immune recognition
Liraglutide, marketed under the brand names Victoza for diabetes management and Saxenda for weight management, is a versatile GLP-1 receptor agonist with a distinct focus on weight loss